Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256,049 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunological Aspects of Approved MS Therapeutics.
Rommer PS, Milo R, Han MH, Satyanarayan S, Sellner J, Hauer L, Illes Z, Warnke C, Laurent S, Weber MS, Zhang Y, Stuve O. Rommer PS, et al. Among authors: zhang y. Front Immunol. 2019 Jul 11;10:1564. doi: 10.3389/fimmu.2019.01564. eCollection 2019. Front Immunol. 2019. PMID: 31354720 Free PMC article. Review.
Clinical trials in multiple sclerosis: milestones.
Zhang Y, Salter A, Cutter G, Stuve O. Zhang Y, et al. Ther Adv Neurol Disord. 2018 Jul 9;11:1756286418785499. doi: 10.1177/1756286418785499. eCollection 2018. Ther Adv Neurol Disord. 2018. PMID: 30034537 Free PMC article. Review.
Evolution of clinical trials in multiple sclerosis.
Zhang Y, Salter A, Wallström E, Cutter G, Stüve O. Zhang Y, et al. Ther Adv Neurol Disord. 2019 Feb 21;12:1756286419826547. doi: 10.1177/1756286419826547. eCollection 2019. Ther Adv Neurol Disord. 2019. PMID: 30833985 Free PMC article. Review.
Clinical trials in multiple sclerosis: potential future trial designs.
Manouchehri N, Zhang Y, Salter A, Hussain RZ, Hartung HP, Hemmer B, Linker R, Segal BM, Cutter G, Stüve O. Manouchehri N, et al. Among authors: zhang y. Ther Adv Neurol Disord. 2019 May 13;12:1756286419847095. doi: 10.1177/1756286419847095. eCollection 2019. Ther Adv Neurol Disord. 2019. PMID: 31205492 Free PMC article. Review.
Differential antibody response to COVID-19 vaccines across immunomodulatory therapies for multiple sclerosis.
Satyanarayan S, Safi N, Sorets T, Filomena S, Zhang Y, Klineova S, Fabian M, Horng S, Tankou S, Miller A, Krieger S, Lublin F, Sumowski J, Katz Sand I. Satyanarayan S, et al. Among authors: zhang y. Mult Scler Relat Disord. 2022 Jun;62:103737. doi: 10.1016/j.msard.2022.103737. Epub 2022 Mar 12. Mult Scler Relat Disord. 2022. PMID: 35533419 Free PMC article.
Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consortium (NYCNIC).
Klineova S, Harel A, Straus Farber R, DeAngelis T, Zhang Y, Hentz R, Leung TM, Fong K, Smith T, Blanck R, Zhovtis-Ryerson L. Klineova S, et al. Among authors: zhang y. Mult Scler Relat Disord. 2021 Oct;55:103153. doi: 10.1016/j.msard.2021.103153. Epub 2021 Jul 19. Mult Scler Relat Disord. 2021. PMID: 34392059 Free PMC article.
256,049 results
You have reached the last available page of results. Please see the User Guide for more information.